1-12 of 169 Products & Services
This 20 mL cyclonic Cinnabar™ spray chamber, with incorporated Helix™, is used with ELAN® 6000, 9000, DRC II, and DRC-e ICP-MS series instruments that utilize torch adapters N8120116 and W1013266.
This quick-change sample introduction module for oil analysis, with cyclonic spray chamber and GemCone™ concentric nebulizer technologies, includes core consumables and components used with Optima™ 4300 V, 5300 V, and 7300 V series instruments.
This 47 mm I.D. PFA M100 spray chamber, with o-ring-free PFA end cap and drain line (N8141425), is used with Optima™ 2x00 DV, 4x00 DV, 5x00 DV, 7x00 DV, and 8x00 ICP-OES series instruments.
This 20 mL baffled cyclonic Twinnabar™ spray chamber, with incorporated Helix™, is used with ELAN® 6000, 9000, DRC II and DRC-e ICP-MS series instruments that utilize torch adapters N8120116 and W1013266.
This cyclonic spray chamber PTFE-coated o-ring kit, for the nebulizer adaptor plug 16/6, (N0776006) is used with all Optima™ ICP-OES and ELAN® and NexION® ICP-MS series instruments.
1-1 of 1 Business Insights
Nanoparticles (NPs) have been of significant interest over the last two decades as they offer attractive benefits for drug delivery to overcome limitations in conventional chemotherapy. Nanoparticles can be engineered to carry both drugs and imaging probes to simultaneously detect and treat cancer. They may also be designed to specifically target diseased tissues and cells in the body. A number of nanoparticlebased cancer therapeutics have been approved for clinical use and/or are currently under development.